(S)-N-(5-((2,4-Dioxo-3,4-dihydroquinazolin-1(2H)-yl)methyl)-2-fluoropyridin-3-yl)-1-(3,3,3-trifluoropropyl)pyrrolidine-3-carboxamide

ID: ALA4083291

PubChem CID: 137648174

Max Phase: Preclinical

Molecular Formula: C22H21F4N5O3

Molecular Weight: 479.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(CCC(F)(F)F)C1

Standard InChI:  InChI=1S/C22H21F4N5O3/c23-18-16(28-19(32)14-5-7-30(12-14)8-6-22(24,25)26)9-13(10-27-18)11-31-17-4-2-1-3-15(17)20(33)29-21(31)34/h1-4,9-10,14H,5-8,11-12H2,(H,28,32)(H,29,33,34)/t14-/m0/s1

Standard InChI Key:  LLBQUOHKCAYWBR-AWEZNQCLSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   17.6810  -14.9612    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.1032  -14.3834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8917  -15.1727    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9826  -14.8076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4170  -15.3982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6805  -15.0441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7914  -14.2379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5967  -14.0895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9624  -15.4341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9393  -16.2508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2673  -15.0034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7929  -14.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5262  -16.2101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5492  -15.3934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8541  -14.9626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1319  -15.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1089  -16.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8081  -16.5960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2212  -16.6409    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.4368  -14.9261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4599  -14.1094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1780  -13.7193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2051  -12.9026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5059  -12.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7878  -12.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0928  -12.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3747  -12.8212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3516  -13.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0467  -14.0687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7648  -13.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5331  -11.6552    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8772  -14.1460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2937  -14.2728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6042  -13.7379    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  4  8  1  0
  9 10  2  0
  9 11  1  0
  6  9  1  1
  4 12  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 13 19  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 21 30  1  0
 25 30  2  0
 24 31  2  0
 22 32  2  0
 20 21  1  0
 16 20  1  0
 11 14  1  0
 12 33  1  0
 33  2  1  0
  2 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4083291

    ---

Associated Targets(Human)

PARP2 Tclin Poly [ADP-ribose] polymerase 2 (1185 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 479.43Molecular Weight (Monoisotopic): 479.1581AlogP: 2.49#Rotatable Bonds: 6
Polar Surface Area: 100.09Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.62CX Basic pKa: 8.18CX LogP: 2.01CX LogD: 1.31
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -1.64

References

1. Zhao H, Ji M, Cui G, Zhou J, Lai F, Chen X, Xu B..  (2017)  Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors.,  25  (15): [PMID:28622906] [10.1016/j.bmc.2017.05.052]

Source